CD4 T lymphocytes from patients with chronic fatigue syndrome have decreased interferon-gamma production and increased sensitivity to dexamethasone. — CFSMEATLAS
CD4 T lymphocytes from patients with chronic fatigue syndrome have decreased interferon-gamma production and increased sensitivity to dexamethasone.
Visser, J, Blauw, B, Hinloopen, B et al. · The Journal of infectious diseases · 1998 · DOI
Quick Summary
This study looked at immune cells called CD4 T cells from ME/CFS patients and found they produced less of a protective immune protein called interferon-gamma compared to healthy people. Interestingly, these cells were also much more sensitive to dexamethasone, a steroid medication—it took 10-20 times less of the drug to suppress certain immune functions in ME/CFS patients than in controls. This suggests that the stress hormone system and immune system may be working abnormally together in ME/CFS.
Why It Matters
This research provides evidence that ME/CFS involves both a dysregulated stress hormone system and abnormal immune responses at the cellular level. Understanding why ME/CFS immune cells are hypersensitive to glucocorticoids could help explain the characteristic post-exertional malaise and guide development of targeted immune therapies. These findings support the biological basis of ME/CFS rather than viewing it as purely psychological.
Observed Findings
CD4 T cells from CFS patients produced significantly less interferon-gamma than control cells
IL-4 production and cell proliferation were comparable between CFS and control groups
Dexamethasone inhibited IL-4 production and proliferation at 10-20 fold lower concentrations in CFS cells than controls
Interferon-gamma suppression by dexamethasone showed equal sensitivity between CFS and control cells
Inferred Conclusions
CFS involves a dysregulated hypothalamic-pituitary-adrenal axis with altered T cell sensitivity to glucocorticoids
Differential sensitivity of specific cytokines or CD4 T cell subsets to glucocorticoids may explain abnormal immune function in CFS
The immune abnormality in CFS is not uniform across all functions but affects specific cytokine responses
Remaining Questions
Why do CFS CD4 cells show increased glucocorticoid sensitivity for some cytokines but not others?
Does this increased sensitivity to glucocorticoids contribute directly to CFS symptoms, and if so, how?
What causes the underlying abnormality in the hypothalamic-pituitary-adrenal axis in CFS patients?
What This Study Does Not Prove
This study does not prove that altered glucocorticoid sensitivity causes ME/CFS symptoms or that it is the primary driver of disease. It cannot establish causation or explain why this abnormality develops. The findings are from cultured cells in a laboratory and may not fully reflect the complexity of immune dysfunction in living patients with ME/CFS.